Okay.
Philip Morris International's 2022 annual report noted the following:
In 2021, our equity method investee, Medicago Inc., initiated additional rounds of equity funding in which we did not participate. As a result, our share of holdings in Medicago Inc. was reduced from approximately 32% at December 31, 2020, to approximately 23% as of December 31, 2021. The ownership dilution resulted in a $0.04 per share favourable impact to diluted EPS and income of $55 million to equity investments and securities (income)/loss, net in the consolidated statements of earnings for the year ended December 31, 2022.
At this committee's meeting last Wednesday, health minister Mark Holland claimed that PMI'S minority position that was held in Medicago did not advance the interests of either nicotine or tobacco. Given that this ownership dilution had a positive financial impact for Philip Morris International, contributing to a net income of $55 million for the year 2021, is it accurate to claim that Philip Morris International's minority position in Medicago did not advance the tobacco company's interest?